• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein.作为载体蛋白的人血清白蛋白会影响无去污剂谷氨酸脱羧酶(GAD65)的抗原呈递。
J Immunol Methods. 2008 May 20;334(1-2):114-21. doi: 10.1016/j.jim.2008.02.006. Epub 2008 Mar 7.
2
Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals.HLA-DRB1*0401阳性个体中谷氨酸脱羧酶65(GAD65)T细胞表位的差异呈现
J Immunol. 1999 Aug 1;163(3):1674-81.
3
Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.血管内皮细胞对胰岛自身抗原GAD的加工和呈递促进自身反应性T细胞的迁移。
Diabetes. 2003 Mar;52(3):717-25. doi: 10.2337/diabetes.52.3.717.
4
GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.谷氨酸脱羧酶65特异性自身抗体增强了来自谷氨酸脱羧酶65的免疫显性T细胞表位的呈递。
Diabetes. 2000 Oct;49(10):1621-6. doi: 10.2337/diabetes.49.10.1621.
5
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.来自一名I型糖尿病患者的、对GAD65具有特异性的自身反应性B细胞克隆对抗原呈递的调节作用。
Clin Exp Immunol. 2004 Jan;135(1):74-84. doi: 10.1111/j.1365-2249.2004.02343.x.
6
COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity.自身抗体和T细胞决定簇在GAD65结构上的羧基末端聚集为自身反应性的分子基础提供了见解。
Diabetes. 2008 May;57(5):1293-301. doi: 10.2337/db07-1461. Epub 2008 Jan 9.
7
Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope.谷氨酸脱羧酶65特异性自身免疫性B淋巴细胞对位于抗体表位内的T细胞决定簇加工处理的抑制作用。
J Immunol. 2002 Jul 15;169(2):665-72. doi: 10.4049/jimmunol.169.2.665.
8
Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice.利用HLA-DR(α1*0101,β1*0401)转基因小鼠鉴定人谷氨酸脱羧酶65的免疫显性T细胞表位。
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8082-7. doi: 10.1073/pnas.94.15.8082.
9
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.利用针对1型糖尿病相关人类MHC II类等位基因DRB1*0401转基因的小鼠鉴定出的来自人谷氨酸脱羧酶的天然加工T细胞表位。
J Clin Invest. 1996 Dec 1;98(11):2597-603. doi: 10.1172/JCI119079.
10
Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.使用人CD4、DQA1*0301、DQB1*0302转基因IA(无)NOD小鼠定位人GAD65的主要DQ8限制性T细胞表位。
Diabetes. 1999 Mar;48(3):469-77. doi: 10.2337/diabetes.48.3.469.

引用本文的文献

1
Immune therapy in type 1 diabetes mellitus.1 型糖尿病的免疫治疗。
Nat Rev Endocrinol. 2013 Feb;9(2):92-103. doi: 10.1038/nrendo.2012.237. Epub 2013 Jan 8.
2
Vaccination against type 1 diabetes.1 型糖尿病疫苗接种。
J Intern Med. 2011 Jun;269(6):626-35. doi: 10.1111/j.1365-2796.2011.02386.x.

本文引用的文献

1
The extraordinary ligand binding properties of human serum albumin.人血清白蛋白非凡的配体结合特性。
IUBMB Life. 2005 Dec;57(12):787-96. doi: 10.1080/15216540500404093.
2
Autoantibodies in diabetes.糖尿病中的自身抗体
Diabetes. 2005 Dec;54 Suppl 2:S52-61. doi: 10.2337/diabetes.54.suppl_2.s52.
3
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.成人起病型自身免疫性糖尿病中GAD65免疫调节安全性的临床证据。
J Diabetes Complications. 2005 Jul-Aug;19(4):238-46. doi: 10.1016/j.jdiacomp.2004.12.003.
4
Diabetes Antibody Standardization Program: first assay proficiency evaluation.糖尿病抗体标准化计划:首次检测能力评估。
Diabetes. 2003 May;52(5):1128-36. doi: 10.2337/diabetes.52.5.1128.
5
Type 1A diabetes mellitus-associated autoimmunity.1型糖尿病相关自身免疫
Endocrinol Metab Clin North Am. 2002 Jun;31(2):391-410, vii-viii. doi: 10.1016/s0889-8529(01)00017-2.
6
Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.控制调控因素:1型糖尿病中的谷氨酸脱羧酶65自身反应性T细胞
J Clin Invest. 2002 Apr;109(7):869-70. doi: 10.1172/JCI15381.
7
Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.用于检测1型糖尿病自身反应性T细胞的谷氨酸脱羧酶65(GAD65)、胰岛素原及胰岛酪氨酸磷酸酶IA-2制剂的特性:第二届国际糖尿病免疫学会1型糖尿病T细胞检测标准化研讨会第二阶段报告
Diabetes. 2001 Aug;50(8):1749-54. doi: 10.2337/diabetes.50.8.1749.
8
Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).来自糖尿病相关自身抗原人谷氨酸脱羧酶65(hGAD65)的天然加工T细胞表位的鉴定与调控。
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1763-8. doi: 10.1073/pnas.98.4.1763.
9
A novel monoclonal antibody specific for the N-terminal end of GAD65.一种针对GAD65 N端的新型单克隆抗体。
J Neuroimmunol. 2001 Feb 1;113(1):63-71. doi: 10.1016/s0165-5728(00)00423-9.
10
Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.来自不同谷氨酸脱羧酶(GAD)抗体阳性表型的自身抗体对谷氨酸脱羧酶(GAD)的识别。
J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9. doi: 10.1210/jcem.85.12.7070.

作为载体蛋白的人血清白蛋白会影响无去污剂谷氨酸脱羧酶(GAD65)的抗原呈递。

Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein.

作者信息

Steed Jordan, Gilliam Lisa K, Harris Robert A, Lernmark Ake, Hampe Christiane S

机构信息

Robert H. Williams Laboratory, Department of Medicine, University of Washington, Health Sciences Building K-165, 1959 Pacific Avenue NE, Seattle, WA 98195-3771, USA.

出版信息

J Immunol Methods. 2008 May 20;334(1-2):114-21. doi: 10.1016/j.jim.2008.02.006. Epub 2008 Mar 7.

DOI:10.1016/j.jim.2008.02.006
PMID:18353353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2442559/
Abstract

The smaller isoform of glutamate decarboxylase (GAD65) is a major autoantigen in type 1 diabetes (TID). Its hydrophobic character requires detergent to keep the protein in solution, which complicates studies of antigen processing and presentation. In this study an attempt was made to replace detergent with human serum albumin (HSA) for in vitro antigen presentation. Different preparations of recombinant human GAD65 solubilized by HSA were incubated with Priess B cells (HLA DRB10401) and antigen presentation was tested with HLA DRB10401-restricted and epitope-specific T33.1 (GAD65 epitope 274-286) and T35 (GAD65 epitope 115-127) T-cell hybridomas. Specific epitope recognition by T33.1 (274-286) and T35 (115-127) cells varied between the different GAD65/HSA preparations, and a reverse pattern of antigen presentation was detected by the two hybridoma. The HSA-specific T-cell hybridoma 17.9 response to the different GAD65/HSA preparations followed the same pattern as that observed for the T33.1 cells. The content of immunoreactive GAD65 measured with four GAD65 antibodies indicated that the lowest GAD65 concentration resulted in the highest 274-286, but the lowest 115-127 presentation. This suggests that HSA-GAD65 interactions qualitatively affect the epitope specificity of GAD65 presentation. HSA may enhance the 274-286 epitope presentation, while suppressing the 115-127 epitope.

摘要

谷氨酸脱羧酶(GAD65)的较小异构体是1型糖尿病(TID)中的主要自身抗原。其疏水性需要去污剂来使蛋白质保持在溶液中,这使得对抗原加工和呈递的研究变得复杂。在本研究中,尝试用人血清白蛋白(HSA)替代去污剂用于体外抗原呈递。将不同制剂的经HSA溶解的重组人GAD65与普里斯B细胞(HLA DRB10401)孵育,并用HLA DRB10401限制性和表位特异性T33.1(GAD65表位274-286)和T35(GAD65表位115-127)T细胞杂交瘤测试抗原呈递。T33.1(274-286)和T35(115-127)细胞对不同GAD65/HSA制剂的特异性表位识别各不相同,并且两种杂交瘤检测到了相反的抗原呈递模式。HSA特异性T细胞杂交瘤17.9对不同GAD65/HSA制剂的反应与T33.1细胞观察到的模式相同。用四种GAD65抗体测量的免疫反应性GAD65含量表明,最低的GAD65浓度导致最高的274-286呈递,但115-127呈递最低。这表明HSA-GAD65相互作用在质量上影响GAD65呈递的表位特异性。HSA可能增强274-286表位呈递,同时抑制115-127表位。